SELENBP1 Antikörper (AA 401-472) (Biotin)
-
- Target Alle SELENBP1 Antikörper anzeigen
- SELENBP1 (Selenium Binding Protein 1 (SELENBP1))
-
Bindungsspezifität
- AA 401-472
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SELENBP1 Antikörper ist konjugiert mit Biotin
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Dog,Cow,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human SBP1/Selenium Binding Protein 1
- Isotyp
- IgG
- Top Product
- Discover our top product SELENBP1 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- SELENBP1 (Selenium Binding Protein 1 (SELENBP1))
- Andere Bezeichnung
- Selenium Binding Protein 1 (SELENBP1 Produkte)
- Hintergrund
-
Synonyms: SBP, SBP1, Selenbp2, Selenium binding protein 2, Selenium binding protein1, SELNBP1, SP56, 56 kDa selenium binding protein.
Background: Selenium is an essential trace element that confers tolerance to toxicity arising through exposure to heavy metals or other reactive xenobiotics. Selenium exhibits potent anticarcinogenic properties, and deficiency of selenium may cause certain neurologic diseases. Both effects are attributed to selenium-binding proteins. Selenium binding protein 1 is down-regulated in lung adenocarcinoma, colorectal cander and ovarian cancer. It is two-fold upregulated in the brains of patients suffering from schizophrenia, and is therefore a biomarker for this disease.
- Gen-ID
- 1954
- Pathways
- Brown Fat Cell Differentiation
-